
Shield Therapeutics plc (STX.L)
- Previous Close
5.50 - Open
5.53 - Bid 5.90 x --
- Ask 6.10 x --
- Day's Range
5.53 - 6.36 - 52 Week Range
3.70 - 12.50 - Volume
11,808,879 - Avg. Volume
2,115,019 - Market Cap (intraday)
65.265M - Beta (5Y Monthly) 1.72
- PE Ratio (TTM)
-- - EPS (TTM)
-0.01 - Earnings Date (est.) --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
16.67
Recent News
View MorePerformance Overview
Trailing total returns as of 8/28/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Analyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
58.85M
-
Enterprise Value
73.31M
-
Trailing P/E
--
-
Forward P/E
285.71
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
1.35
-
Price/Book (mrq)
--
-
Enterprise Value/Revenue
1.70
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-17.69%
-
Return on Assets (ttm)
-4.37%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
58.62M
-
Net Income Avi to Common (ttm)
-10.37M
-
Diluted EPS (ttm)
-0.01
Balance Sheet and Cash Flow
-
Total Cash (mrq)
8.35M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-3.21M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.

